The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease

Title
The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease
Authors
Keywords
-
Journal
CIRCULATION
Volume 148, Issue 19, Pages 1455-1458
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-11-07
DOI
10.1161/circulationaha.123.066600

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More